BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
64
Frequently Asked Questions
What is Market Cap of BioAge Labs Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. BioAge Labs Inc. market cap is $183.19M.
What is the 52-week high for BioAge Labs Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. BioAge Labs Inc. 52 week high is $26.62 as of September 24, 2025.
What is the 52-week low for BioAge Labs Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BioAge Labs Inc. 52 week low is $2.88 as of September 24, 2025.
What is BioAge Labs Inc. stock price today?
BioAge Labs Inc. stock price today is $4.94.
What was BioAge Labs Inc. stock price yesterday?
BioAge Labs Inc. stock price yesterday was $5.11.
What is the PE ratio of BioAge Labs Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. BioAge Labs Inc.’s P/E ratio is -2.29.
What is the Price-to-Book ratio of BioAge Labs Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. BioAge Labs Inc. P/B ratio is 0.6215.
What is the 50-day moving average of BioAge Labs Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. BioAge Labs Inc. 50-day moving average is $4.65.
